The Hopelessness Theory of Depression : Clinical Utility and Generalizability. / Haeffel, Gerald J.; Hershenberg, Rachel; Goodson, Jason T.; Hein, Sascha; Square, Amanda; Grigorenko, Elena L.; Chapman, John.
In: Cognitive Therapy and Research, Vol. 41, No. 4, 01.08.2017, p. 543-555.Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - The Hopelessness Theory of Depression
T2 - Clinical Utility and Generalizability
AU - Haeffel, Gerald J.
AU - Hershenberg, Rachel
AU - Goodson, Jason T.
AU - Hein, Sascha
AU - Square, Amanda
AU - Grigorenko, Elena L.
AU - Chapman, John
PY - 2017/8/1
Y1 - 2017/8/1
N2 - To date, “basic” research has dominated the empirical literature on hopelessness theory. The next logical step in this area of research is to determine if the theory can be used to help people. We conducted three studies to determine if the cognitive vulnerability factor featured in hopelessness theory could be reliably measured in diverse samples in a treatment context and if it could predict depressive therapeutic outcomes. Study 1 used a sample of male juvenile detainees (n = 296; 70% from underrepresented groups) and found that cognitive vulnerability moderated the effectiveness of a social problem solving training intervention. Study 2 used a clinical sample of U.S. Veterans (n = 16; 56% from underrepresented groups) enrolled in a cognitive behavioral therapy group for depression and found that cognitive vulnerability predicted post-therapy depressive outcomes. In both Study 1 and Study 2, higher levels of cognitive vulnerability resulted in poorer treatment outcomes (i.e., greater post-treatment levels of depressive symptoms). Study 3 used a clinical sample of U.S. Veterans (n = 76; 67% from underrepresented groups) enrolled in a behavior activation group and found no effect of cognitive vulnerability on post-therapy depressive outcomes. The results of the three studies indicate that hopelessness theory’s cognitive vulnerability construct can be reliably measured in diverse samples in real world clinical contexts and that it has the potential to be a useful predictor of clinical outcomes in the context of cognitively focused treatments.
AB - To date, “basic” research has dominated the empirical literature on hopelessness theory. The next logical step in this area of research is to determine if the theory can be used to help people. We conducted three studies to determine if the cognitive vulnerability factor featured in hopelessness theory could be reliably measured in diverse samples in a treatment context and if it could predict depressive therapeutic outcomes. Study 1 used a sample of male juvenile detainees (n = 296; 70% from underrepresented groups) and found that cognitive vulnerability moderated the effectiveness of a social problem solving training intervention. Study 2 used a clinical sample of U.S. Veterans (n = 16; 56% from underrepresented groups) enrolled in a cognitive behavioral therapy group for depression and found that cognitive vulnerability predicted post-therapy depressive outcomes. In both Study 1 and Study 2, higher levels of cognitive vulnerability resulted in poorer treatment outcomes (i.e., greater post-treatment levels of depressive symptoms). Study 3 used a clinical sample of U.S. Veterans (n = 76; 67% from underrepresented groups) enrolled in a behavior activation group and found no effect of cognitive vulnerability on post-therapy depressive outcomes. The results of the three studies indicate that hopelessness theory’s cognitive vulnerability construct can be reliably measured in diverse samples in real world clinical contexts and that it has the potential to be a useful predictor of clinical outcomes in the context of cognitively focused treatments.
KW - Clinical context
KW - Cognitive vulnerability
KW - Depression
KW - Effectiveness
KW - Generalizability
KW - Hopelessness theory
UR - http://www.scopus.com/inward/record.url?scp=85014639676&partnerID=8YFLogxK
U2 - 10.1007/s10608-017-9833-1
DO - 10.1007/s10608-017-9833-1
M3 - Article
AN - SCOPUS:85014639676
VL - 41
SP - 543
EP - 555
JO - Cognitive Therapy and Research
JF - Cognitive Therapy and Research
SN - 0147-5916
IS - 4
ER -
ID: 62762135